ARCHIVES

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

May 9, 2014

Senate Confirms McClellan For FDA

October 25, 2002

HHS Web Site Opens On Health Disparities

July 17, 1998

Henschke: I-ELCAP Plans to Enroll 100,000 Patients In Controversial Screening Trial

June 24, 2011

ACCC Members To Lobby, Hear Discussion on Oncology Unit

January 6, 1978

Richard Bloch’s Dream Of Empowering Patients Had Rough Beginning

October 11, 1996